{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Nektar Therapeutics", "item": "https://www.patentleaderboard.com/2021/company/nektar-therapeutics"}, {"@type": "ListItem", "position": 4, "name": "Michael A. Eldon", "item": "https://www.patentleaderboard.com/2021/inventor/fl:mi_ln:eldon-2"}]}

Home › 2021 › Nektar Therapeutics › Michael A. Eldon

Michael A. Eldon — 1 Patent in 2021

NTNektar Therapeutics: 1 patents #24 of 33Top 75%

Redwood City, CA: #465 of 1,107 inventorsTop 45%

California: #26,007 of 66,859 inventorsTop 40%

Overall (2021): #334,459 of 548,734Top 65%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11033631	Methods of treating CYP2D6 alternative metabolizers	C. Simone Jude-Fishburn, Hema Gursahani, Myong Gyong Lee	2021-06-15	$33,406,000

Michael A. Eldon — 1 Patent in 2021

Issued Patents 2021

Patent Widget